article thumbnail

Report: Venture Capital Fund Linked To Convicted Felon In Lompoc

socalTECH

A new report, published this morning by Fortune, says that a "new" venture capital fund--announced last week in officially looking press releases-- appears to be linked to a convicted inmate, currently imprisoned in Lompoc. Fortune says it does not know who has been sending out press releases from the company.

article thumbnail

With $20M, UCSD Spinout Jecure To Press New Attack On NASH

Xconomy

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Canoo, the electric vehicle startup formed from Faraday Future’s ashes, seeks $200 million

TechCrunch LA

Less than a month after rebranding as Canoo , the startup electric vehicle company formerly known as Evelozcity is on the hunt for $200 million in new capital. Canoo plans to use blockchain technology to secure its subscription services and ensure an asset light approach to development by outsourcing its manufacturing in the U.S.

article thumbnail

What Makes a Successful Startup Community? Is it Possible to Build One Where You Live?

Both Sides of the Table

Recently I wrote a post arguing to make the definition of a Startup more inclusive than that to which Silicon Valley, fueled by Venture Capital return profiles, would sometimes like to attach to the word. Local Capital – I do believe that you’ll struggle to get a community started without some local capital.

Startup 378
article thumbnail

Car Sharing Firm Zipcar Heading To Los Angeles

socalTECH

Zipcar has been inviting the press to an event tomorrow with L.A. Car sharing startups have become immensely popular in areas such as Boston and San Francisco, with heavy competition between Zipcar, Relayrides, and Getaround.

article thumbnail

Inhibrix Pulls In $40M to Press Ahead With Cancer Drug Clinical Trials

Xconomy

Inhibrx, developer of protein drugs targeting cancer and other diseases, has raised $40 million from the hedge fund Viking Global Investors as the biotech steers several programs through early-stage clinical trials. The La Jolla, CA-based company was founded in 2010 by Mark Lappe, Brendan Eckelman, and Quinn Deveraux.

Press 67
article thumbnail

Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

Xconomy

Still, politicians have pressed companies to move even faster. A race has one winner and public health officials have said we’ll need multiple vaccines to address the global need. Vaccine developers have progressed to pivotal testing with unprecedented speed, compressing the years-long clinical testing process into months.

Press 76